These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19126235)

  • 1. A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis.
    Fendrick AM; Greenberg BP
    Osteopath Med Prim Care; 2009 Jan; 3():1. PubMed ID: 19126235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
    Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk: Decades Later, Any New Lessons Learned?
    Minhas D; Nidhaan A; Husni ME
    Rheum Dis Clin North Am; 2023 Feb; 49(1):179-191. PubMed ID: 36424024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E; Nedjar H
    Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
    Rostom A; Moayyedi P; Hunt R;
    Aliment Pharmacol Ther; 2009 Mar; 29(5):481-96. PubMed ID: 19053986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and Treatment of NSAID Gastropathy.
    Gargallo CJ; Sostres C; Lanas A
    Curr Treat Options Gastroenterol; 2014 Dec; 12(4):398-413. PubMed ID: 25209136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis.
    van Walsem A; Pandhi S; Nixon RM; Guyot P; Karabis A; Moore RA
    Arthritis Res Ther; 2015 Mar; 17(1):66. PubMed ID: 25879879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice Advisory on the Appropriate Use of NSAIDs in Primary Care.
    Ho KY; Cardosa MS; Chaiamnuay S; Hidayat R; Ho HQT; Kamil O; Mokhtar SA; Nakata K; Navarra SV; Nguyen VH; Pinzon R; Tsuruoka S; Yim HB; Choy E
    J Pain Res; 2020; 13():1925-1939. PubMed ID: 32821151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of rofecoxib, a cyclooxygenase-2-specific inhibitor, for the treatment of non-cancer pain: a review.
    Fine PG;
    J Pain; 2002 Aug; 3(4):272-83. PubMed ID: 14622751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetaminophen for osteoarthritis.
    Towheed TE; Maxwell L; Judd MG; Catton M; Hochberg MC; Wells G
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004257. PubMed ID: 16437479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
    Matheson AJ; Figgitt DP
    Drugs; 2001; 61(6):833-65. PubMed ID: 11398914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
    Scheiman JM; Hindley CE
    Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.
    Katz JN; Smith SR; Collins JE; Solomon DH; Jordan JM; Hunter DJ; Suter LG; Yelin E; Paltiel AD; Losina E
    Osteoarthritis Cartilage; 2016 Mar; 24(3):409-18. PubMed ID: 26525846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database.
    Schnitzer TJ; Kong SX; Mavros PP; Straus WL; Watson DJ
    Clin Ther; 2001 Dec; 23(12):1984-98. PubMed ID: 11813933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NSAIDs and serious cardiovascular disorders: especially cox-2 inhibitors and diclofenac.
    Prescrire Int; 2016 Jan; 25(167):14-6. PubMed ID: 26942254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial.
    Solomon DH; Husni ME; Wolski KE; Wisniewski LM; Borer JS; Graham DY; Libby P; Lincoff AM; Lüscher TF; Menon V; Yeomans ND; Wang Q; Bao W; Berger MF; Nissen SE;
    Arthritis Rheumatol; 2018 Apr; 70(4):537-546. PubMed ID: 29266879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.